Second radiation for prostate cancer that returns locally
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a second round of precise, high-dose radiation (stereotactic body radiotherapy) for men whose prostate cancer has come back only in the prostate after their first radiation treatment. It aims to control the recurrence with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your prostate cancer must have come back only in the prostate area after your first radiation treatment.
- It has been at least 2 years since your first round of radiation therapy.
- You are in good overall health and able to care for yourself (Zubrod score 0–1).
- The recurrence is confirmed by a biopsy, or by MRI and PET-PSMA scans along with rising PSA levels.
- The cancer has not spread to lymph nodes or other organs, and if it has spread a little, it can still be treated with local therapies.
- You have not had brachytherapy (internal radiation seeds) before, and you do not have severe urinary symptoms or other conditions that could affect the safety of the new radiation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a high-dose radiation treatment (brachytherapy) that places tiny radioactive seeds directly into the area where your prostate was. It is for men whose prostate cancer has returned only in that area after having their prostate removed.
This study tests a focused radiation treatment (SBRT) to a small, clearly identified spot in the prostate for men whose prostate cancer has come back after prior external beam radiation. It may help control cancer while limiting radiation to the rest of the prostate and nearby organs.
This trial tests a precise type of radiation (called SBRT) to the prostate bed for men whose PSA starts rising after prostate removal surgery. It aims to see if this targeted approach can effectively treat the recurrence without needing long-term hormone therapy.
This trial tests a new way of delivering radiation for prostate cancer that has come back after prostate surgery. It may help control the cancer by targeting the “prostate bed” area or nearby lymph nodes where it returned.
This study tests a focused (“salvage”) brachytherapy—radiation placed directly near the prostate—to treat prostate cancer that has returned after earlier radiation. It may help control the tumor while limiting radiation exposure to surrounding tissues, based on how well people fit the study’s safety and cancer details.
This trial tests a combination of MRI-guided brachytherapy and targeted radiation for prostate cancer that has come back after surgery. It is for people whose cancer has returned only in the prostate bed (the area where the prostate used to be) and can be seen on scans.
Hear when a new Radiotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.